Recent Updates
Recently added Catalysts
XTNT Positive Sentiment

Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024

Thursday, November 7, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Xtant Medical Holdings, Inc. has announced the upcoming release of its financial results for the third quarter of 2024, which will occur on November 12, 2024. The company specializes in surgical solutions for spinal disorders, indicating a focus on a critical area of healthcare. This announcement reflects the company's commitment to keeping stakeholders informed.
Price reaction · baseline $0.53 (2024-11-07T15:43:00.000Z) · hit during market hours · 3 other XTNT headline(s) in the window, move may be shared
day 0 close · peak
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Xtant Medical is set to release its financial results soon.
  • The company focuses on surgical solutions for spinal disorders.
  • The announcement indicates transparency and communication with investors.

Full Press Release Details

BELGRADE, MT / ACCESSWIRE / November 7, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September

Frequently Asked Questions

When will Xtant Medical release its Q3 2024 results?

Xtant Medical will release its Q3 2024 financial results on November 12, 2024.

What does Xtant Medical focus on?

Xtant Medical focuses on surgical solutions for the treatment of spinal disorders.

ShareAdd on Google
Tags: XTNT Viatris Investor Conferences Healthcare Xtant Medical financial results spinal disorders surgical solutions
Last updated: Nov 7, 2024

Biotech snapshot

Cash runway
$10M liquidity · $2M/mo burn
~4 mo
High dilution risk